Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Charles River Laboratories International - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CRL
New York
2830
www.criver.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Charles River Laboratories International
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
- Dec 11th, 2025 6:00 am
Akadeum Life Sciences Announces Establishment of the Akadeum CDMO Alliance Program
- Dec 9th, 2025 7:16 am
1 Profitable Stock with Exciting Potential and 2 We Avoid
- Dec 8th, 2025 9:32 pm
What Charles River Laboratories International (CRL)'s Strengthening DSA Bookings Trend Means For Shareholders
- Dec 7th, 2025 12:08 am
T. Rowe Price Transitions to Charles River’s Enterprise Multi-Asset Investment Management Platform
- Dec 4th, 2025 6:30 am
Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know
- Dec 3rd, 2025 2:55 pm
Charles River Laboratories to Present at Evercore Healthcare Conference
- Dec 1st, 2025 6:00 am
What Makes Charles River Laboratories (CRL) an Investment Bet?
- Nov 24th, 2025 5:56 am
Does Charles River’s Lowered Guidance After a Strong Quarter Signal Shifting Priorities for CRL?
- Nov 22nd, 2025 12:10 am
Charles River Laboratories Stock: Is Wall Street Bullish or Bearish?
- Nov 21st, 2025 1:24 am
MA life sciences company Charles River Laboratories to lay off dozens of workers in 2026
- Nov 20th, 2025 9:54 am
Charles River (CRL) International Revenue Performance Explored
- Nov 17th, 2025 7:15 am
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
- Nov 17th, 2025 6:00 am
Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest
- Nov 16th, 2025 8:37 pm
5 Must-Read Analyst Questions From Charles River Laboratories’s Q3 Earnings Call
- Nov 11th, 2025 10:32 pm
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
- Nov 11th, 2025 1:55 pm
3 Healthcare Stocks We Approach with Caution
- Nov 9th, 2025 9:45 pm
Charles River Labs (CRL) Is Down 6.7% After Strategic Overhaul and $1B Buyback Plan Announced
- Nov 7th, 2025 8:11 pm
Charles River Labs (CRL): Assessing Valuation Following Recent Volatility and Share Price Recovery
- Nov 7th, 2025 7:12 am
CRL Q3 Deep Dive: Portfolio Streamlining and End Market Stabilization Shape Outlook
- Nov 5th, 2025 10:31 pm
Scroll